The Efficacy of Zinc Phthalocyanine Nanoconjugate on Melanoma Cells Grown as Three-Dimensional Multicellular Tumour Spheroids

Melanoma remains a major public health concern that is highly resistant to standard therapeutic approaches. Photodynamic therapy (PDT) is an underutilised cancer therapy with an increased potency and negligible side effects, and it is non-invasive compared to traditional treatment modalities. Three-...

Full description

Saved in:
Bibliographic Details
Main Authors: Nkune Williams Nkune (Author), Heidi Abrahamse (Author)
Format: Book
Published: MDPI AG, 2023-08-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_5bedd5beb34b4dd09be3deb95e5ebf9f
042 |a dc 
100 1 0 |a Nkune Williams Nkune  |e author 
700 1 0 |a Heidi Abrahamse  |e author 
245 0 0 |a The Efficacy of Zinc Phthalocyanine Nanoconjugate on Melanoma Cells Grown as Three-Dimensional Multicellular Tumour Spheroids 
260 |b MDPI AG,   |c 2023-08-01T00:00:00Z. 
500 |a 10.3390/pharmaceutics15092264 
500 |a 1999-4923 
520 |a Melanoma remains a major public health concern that is highly resistant to standard therapeutic approaches. Photodynamic therapy (PDT) is an underutilised cancer therapy with an increased potency and negligible side effects, and it is non-invasive compared to traditional treatment modalities. Three-dimensional multicellular tumour spheroids (MCTS) closely resemble in vivo avascular tumour features, allowing for the more efficient and precise screening of novel anticancer agents with various treatment combinations. In this study, we utilised A375 human melanoma spheroids to screen the phototoxic effect of zinc phthalocyanine tetrasulfonate (ZnPcS<sub>4</sub>) conjugated to gold nanoparticles (AuNP). The nanoconjugate was synthesised and characterised using ultraviolet-visible spectroscopy, a high-resolution transmission electron microscope (TEM), dynamic light scattering (DLS), and zeta potential (ZP). The phototoxicity of the nanoconjugate was tested on the A375 MCTS using PDT at a fluency of 10 J/cm<sup>2</sup>. After 24 h, the cellular responses were evaluated via microscopy, an MTT viability assay, an ATP luminescence assay, and cell death induction using annexin propidium iodide. The MTT viability assay demonstrated that the photoactivated ZnPcS<sub>4</sub>, at a concentration of 12.73 µM, caused an approximately 50% reduction in the cell viability of the spheroids. When conjugated to AuNPs, the latter significantly increased the cellular uptake and cytotoxicity in the melanoma spheroids via the induction of apoptosis. This novel Zinc Phthalocyanine Nanoconjugate shows promise as a more effective PDT treatment modality. 
546 |a EN 
690 |a photodynamic therapy 
690 |a zinc phthalocyanine 
690 |a gold nanoparticles 
690 |a three-dimensional multicellular tumour spheroids 
690 |a Pharmacy and materia medica 
690 |a RS1-441 
655 7 |a article  |2 local 
786 0 |n Pharmaceutics, Vol 15, Iss 9, p 2264 (2023) 
787 0 |n https://www.mdpi.com/1999-4923/15/9/2264 
787 0 |n https://doaj.org/toc/1999-4923 
856 4 1 |u https://doaj.org/article/5bedd5beb34b4dd09be3deb95e5ebf9f  |z Connect to this object online.